TRPV1 and dementia: Our study demonstrated that TRPV1 prevented cognitive decline owing to loss of masticatory function and suggested that TRPV1 may be an effective molecular target and its agonist, capsaicin, may be applied to maintain brain function in patients who are bedridden or have dementia and have difficulty receiving prosthetic treatment.